アムピシリン・スルバクタムの集団薬動学モデル 感染症の成人の患者: 系統的レビュー
Mohananasunthari Poornachandran1, Sabariah Noor Harun1, Teh Sin Yin2
1School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang, Malaysia.
Therapeutic drug monitoring
|September 3, 2025
まとめ
大人のアンピシリン・スルバクタムの薬理学 (PK) は,腎機能と疾患状態によって影響を受けます. 投与戦略を最適化し,臨床使用のためのモデルの信頼性を向上させるためにさらなる研究が必要である.
科学分野:
- 薬理学について
- 臨床薬局
- 薬の代謝と薬動力学
背景:
- アンピシリン・スルバクタムは肺炎とAcinetobacter baumannii感染症の第一線治療である.
- 大人における静脈内アンピシリン・スルバクタムのいくつかの集団薬動学 (PK) 試験が存在します.
- 効果的な治療には,PKの変性を理解することが重要です.
研究 の 目的:
- 大人のアンピシリン・スルバクタムの公表された集団PKモデルを体系的に検討し,比較する.
- アンピシリン- スルバクタムのPKパラメータに影響を与える共変数を特定する.
主な方法:
- PubMedとScopusで広範な文献検索が行われました.
- 対象となった研究は,成人患者における静脈注射アンピシリン・スルバクタムの集団PKモデルに焦点を当てた.
- 関連商品は参考リストから特定された.
主要な成果:
- 2つのコンパートメントモデルを用いた5つの研究が検討された.
- アンピシリンとスルバクタムは,類似したクリアランス (CL) と分布量 (Vd) を有する類似したPKプロファイルを示した.
- PKに影響を与えた重要な共同変数は,クレアチニンクリアランス (CLcr),血清クレアチニン (SCr),体表面積,体重,心不全でした.
結論:
- アンピシリン・スルバクタムのクリアランスは主に腎機能と疾患状態によって影響されます.
- レビューされた研究では,PKモデルの外部検証は報告されなかった.
- 投与戦略を洗練し,臨床適用のためのPKモデルの信頼性を高めるために,さらなる研究が必要である.
さらに関連する動画
関連する概念動画
01:26Pharmacokinetic Models: Comparison and Selection Criterion
147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
223
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
223
01:20Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
198
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
198
01:12Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124